Mucormycosis is a highly angioinvasive infection. Antifungal agents with a poor site penetration adversely affect the treatment strategy. Surgical resection is the cornerstone intervention for mucormycosis. Clinicians should avoid delaying surgery in patients with stable underlying diseases despite operative risks.
A timely decision to undergo surgical intervention can be crucial to improve the survival rate in patients. Join the exclusive Surgical Suite session with Dr. Satish Jain, senior ENT surgeon , as he shares a live demonstration on the surgical intervention for mucormycosis , on 6th October 2021, 5 PM onwards . Stay tuned!
